Northwestern Medicine scientists have developed a more effective way of creating nanotherapeutic vaccines and medicines, according to a study published in ACS Nano.
Northwestern Medicine scientists have developed a molecular “scaffold” capable of enhancing electrical activity and growth in neurons, which may prove useful in treating spinal cord injuries, per results published in ACS Nano.
Transgender women and Black gay and bisexual men in Chicago are nearly twice as likely to contract syphilis at some point in their lives as white gay men, according to a new study.
Combining an immune checkpoint inhibitor with standard chemotherapy improved quality of life for patients with advanced stomach cancer or esophageal cancer compared to chemotherapy alone, according to recent findings published in The Journal of Clinical Oncology.
A combination immunotherapy treatment of nivolumab plus ipilimumab was associated with no improvement in survival for advanced cancers other than melanoma, when compared to nivolumab alone, according to a recent Northwestern Medicine meta-analysis published in JAMA Oncology.
More than 60 percent of physicians and medical students reporting delaying having children and building a family due to medical training, with half also having regretted doing so, according to recent survey findings published in JAMA Internal Medicine.
Northwestern University investigators have developed the first electronic device for continuously monitoring the health of transplanted organs in real time.
Electronic health record-based messages delivered solely to clinicians increased referral to tobacco use treatment for cancer patients who smoke, according to a recent study published in the Journal of Clinical Oncology.
Sexual minority women have a higher risk of postpartum depression but are less likely to have their sexual identities documented in electronic medical records, according to a Northwestern Medicine study published in JAMA Psychiatry.
Combining immunotherapy with a tumor-targeted virus may help extend survival in some patients with recurrent glioblastoma, according to the results of a trial published in Nature Medicine.
Notifications